NIH-funded research R37 grant

Compact upright proton therapy for much faster treatments

Official title: A compact beam delivery system enabling ultra-fast dose delivery for upright proton therapy

Funded at Massachusetts General Hospital · NIH-11294180 · Data updated 2026-11-12

This project builds a smaller proton therapy beam-delivery system so people with cancer—especially children and those with moving tumors—can get treatments in seconds instead of minutes.

More Proton Therapy research and trials

Quick facts

Grant typeR37 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startMarch 1, 2024
Project endFebruary 28, 2029
Funding year2026
Award (this year)$487,665
NIH project number5R37CA288343-03
Project IDNIH-11294180 on NIH RePORTER

Who could benefit from this research

Could help

People whose cancers are treated with proton therapy—particularly pediatric patients and those with tumors that move with breathing—would be the most likely candidates for related clinical validation or future treatments.

Less likely to help

Patients whose cancers are not managed with proton therapy or who already do well with conventional radiotherapy may not see direct benefit from this technology in the near term.

What this research studies

This project will make proton therapy faster and more compact by using a new beam design (Fixed‑Field Alternating Gradient) and an ultra‑fast energy degrader. The team will build and test a full‑size degrader prototype, simulate the beam transport, and design the system to fit inside a single upright treatment room. Delivering each treatment field in a few seconds could help doctors treat tumors that move with breathing more accurately and reduce motion-related side effects. Shorter sessions and lower facility costs could make proton therapy more comfortable and available to more patients, including children.

Why it matters

Potential benefit: If successful, patients could have much shorter treatment sessions, improved accuracy for moving tumors, and wider access to proton therapy at lower cost.

How similar studies have gone: Compact proton systems and beam‑delivery improvements exist, but combining FFA lattices with an ultra‑fast degrader for upright, single‑room treatment is relatively novel and early‑stage.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Nesteruk, Konrad Pawel — Massachusetts General Hospital
  • Study coordinator: Nesteruk, Konrad Pawel

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.